These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24396453)

  • 101. PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases.
    Wang J; Wang F; Xie D; Zhou M; Liao J; Wu H; Dai Y; Huang J; Zhao Y
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839671
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles.
    Mollaeva MR; Nikolskaya E; Beganovskaya V; Sokol M; Chirkina M; Obydennyi S; Belykh D; Startseva O; Mollaev MD; Yabbarov N
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943088
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Encapsulation of Cyclosporine A-Loaded PLGA Nanospheres in Alginate Microbeads for Anti-Inflammatory Application.
    Win SY; Chavalitsarot M; Eawsakul K; Ongtanasup T; Nasongkla N
    ACS Omega; 2024 Feb; 9(6):6901-6911. PubMed ID: 38371838
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release.
    Du M; Wang T; Feng R; Zeng P; Chen Z
    Front Bioeng Biotechnol; 2023; 11():1144963. PubMed ID: 36911192
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles.
    Zuo H; Tao J; Wang M; Xie X; Sun M
    RSC Adv; 2022 Sep; 12(43):28104-28112. PubMed ID: 36320259
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity.
    Niazi M; Zakeri-Milani P; Soleymani-Goloujeh M; Mohammadi A; Sarfraz M; Löbenberg R; Najafi-Hajivar S; Shahbazi-Mojarrad J; Farshbaf M; Valizadeh H
    Iran J Basic Med Sci; 2021 Mar; 24(3):383-390. PubMed ID: 33995950
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Further Evidence of Possible Therapeutic Uses of
    Mota AH; Duarte N; Serra AT; Ferreira A; Bronze MR; Custódio L; Gaspar MM; Simões S; Rijo P; Ascensão L; Faísca P; Viana AS; Pinto R; Kumar P; Almeida AJ; Reis CP
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291738
    [No Abstract]   [Full Text] [Related]  

  • 108. A Therapeutic Sheep in Metastatic Wolf's Clothing: Trojan Horse Approach for Cancer Brain Metastases Treatment.
    Liu HJ; Wang M; Shi S; Hu X; Xu P
    Nanomicro Lett; 2022 Apr; 14(1):114. PubMed ID: 35482117
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Cellular regeneration and proliferation on polymeric 3D inverse-space substrates and the effect of doxorubicin.
    Bobade CD; Nandi S; Kale NR; Banerjee SS; Patil YN; Khandare JJ
    Nanoscale Adv; 2020 Jun; 2(6):2315-2325. PubMed ID: 36133387
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Highly Potent and Intestine Specific P-Glycoprotein Inhibitor to Enable Oral Delivery of Taxol.
    Zhou X; Zhang P; Yang Y; Shi W; Liu L; Lai Z; Zhang X; Pan P; Li L; Du J; Qian H; Cui S
    Angew Chem Int Ed Engl; 2024 Nov; 63(45):e202412649. PubMed ID: 39137118
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Phytic acid-modified CeO
    Tian Z; Zhao J; Zhao S; Li H; Guo Z; Liang Z; Li J; Qu Y; Chen D; Liu L
    Nano Res; 2022; 15(5):4334-4343. PubMed ID: 35126877
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process
    Kang NW; Visetvichaporn V; Nguyen DT; Shin EK; Kim D; Kim MJ; Yoo SY; Lee JY; Kim DD
    Mater Today Bio; 2023 Apr; 19():100591. PubMed ID: 36873733
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Retraction Note to: Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells.
    Alfaifi MY; Shati AA; Elbehairi SEI; Fahmy UA; Alhakamy NA; Md S
    3 Biotech; 2024 Jun; 14(6):167. PubMed ID: 38828097
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Correction: Simultaneous therapeutic and diagnostic applications of magnetic PLGA nanoparticles loaded with doxorubicin in rabbit.
    Salmasi Z; Kamali H; Rezaee H; Nazeran F; Jafari Z; Eisvand F; Teymouri M; Khordad E; Mosafer J
    Drug Deliv Transl Res; 2024 Oct; ():. PubMed ID: 39405031
    [No Abstract]   [Full Text] [Related]  

  • 115. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.
    Haider M; Elsherbeny A; Pittalà V; Consoli V; Alghamdi MA; Hussain Z; Khoder G; Greish K
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163777
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Applying Box-Behnken Design for Formulation and Optimization of PLGA-Coffee Nanoparticles and Detecting Enhanced Antioxidant and Anticancer Activities.
    Sharaf NS; Shetta A; Elhalawani JE; Mamdouh W
    Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012166
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells.
    Nassir AM; Shahzad N; Ibrahim IAA; Ahmad I; Md S; Ain MR
    Saudi Pharm J; 2018 Sep; 26(6):876-885. PubMed ID: 30202231
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The potential of multi-compound nanoparticles to bypass drug resistance in cancer.
    Da Silva CG; Peters GJ; Ossendorp F; Cruz LJ
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):881-894. PubMed ID: 28887666
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.
    Ahmad J; Akhter S; Greig NH; Kamal MA; Midoux P; Pichon C
    Curr Pharm Des; 2016; 22(28):4360-4373. PubMed ID: 27319945
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.